Insitro

Insitro is a data-driven drug discovery and development company that integrates high-throughput cellular biology, human genetics, and machine learning to build disease models. The enterprise uses robotic automation and induced pluripotent stem cells to generate biological datasets that train predictive neural networks to identify novel drug targets and patient populations. By closing the loop between machine learning predictions and experimental testing, Insitro aims to accelerate medicine discovery.